Citation Impact

Citing Papers

Anti-HIV natural products
2005
Self‐Assembly of Antimicrobial Peptides on Gold Nanodots: Against Multidrug‐Resistant Bacteria and Wound‐Healing Application
2015
Asymmetric Synthesis of Fluorinated Flavanone Derivatives by an Organocatalytic Tandem Intramolecular Oxa‐Michael Addition/Electrophilic Fluorination Reaction by Using Bifunctional Cinchona Alkaloids
2009
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Synthesis and antitumor evaluation of methyl spongoate analogs
2010
Synthesis of Natural Product Inspired Compound Collections
2009
Novel antiviral agents: a medicinal plant perspective
2003
Size-selective pH-operated megagates on mesoporous silica materials
2012 StandoutNobel
CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
2012 Standout
Catalytic asymmetric conjugate addition of Grignard reagents to chromones
2013 StandoutNobel
Marine natural products
1990 Standout
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones
2009
Natural Pigments: Carotenoids, Anthocyanins, and Betalains — Characteristics, Biosynthesis, Processing, and Stability
2000 Standout
Actinohivin, a Novel Anti-HIV Protein from an Actinomycete That Inhibits Syncytium Formation: Isolation, Characterization, and Biological Activities
2001 StandoutNobel
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Brønsted Acid Catalyzed Asymmetric SN2‐Type O‐Alkylations
2013 StandoutNobel
Antibacterial anti-oxidant electroactive injectable hydrogel as self-healing wound dressing with hemostasis and adhesiveness for cutaneous wound healing
2017 Standout
Coumarins
1997
Recent progress in the development of coumarin derivatives as potent anti‐HIV agents
2003 Standout
Phosphorylated 3‐Heteroarylcoumarins and Their Use in Fluorescence Microscopy and Nanoscopy
2012 StandoutNobel
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Protein aggregation and neurodegenerative disease
2004 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents
2013
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Synthesis of Biologically Relevant Biflavanoids – A Review
2007
Advances in flavonoid research since 1992
2000 Standout
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
2000
Drug discovery from medicinal plants
2005 Standout
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Analysis of condensed and hydrolysable tannins from commercial plant extracts
2006
Asymmetric Intramolecular Oxa‐Michael Addition of Activated α,β‐Unsaturated Ketones Catalyzed by a Chiral N,N′‐Dioxide Nickel(II) Complex: Highly Enantioselective Synthesis of Flavanones
2008
Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers
2016
Synthesis of chromanones: a novel palladium-catalyzed Wacker-type oxidative cyclization involving 1,5-hydride alkyl to palladium migration
2007
Biological effects of essential oils – A review
2007 Standout
Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?
2003
Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
2009
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Selenium-Based Solid-Phase Synthesis of Benzopyrans I: Applications to Combinatorial Synthesis of Natural Products
2000
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Anti HIV-1 Active Calophyllum Coumarins: Distribution, Chemistry, and Activity
2000
Pd-Catalyzed Cross-Coupling of Aryllithium Reagents with 2-Alkoxy-Substituted Aryl Chlorides: Mild and Efficient Synthesis of 3,3′-Diaryl BINOLs
2014 StandoutNobel
Room-Temperature Ionic Liquids: Solvents for Synthesis and Catalysis. 2
2011 Standout
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay
2002
(+)-Myristinin A, a Naturally Occurring DNA Polymerase β Inhibitor and Potent DNA-Damaging Agent
2005
Antibiotics for community-acquired pneumonia in adult outpatients
2014
A facile synthetic route to 2-trifluoromethyl-substituted polyfunctionalized chromenes and chromones
2011
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Mitsunobu and Related Reactions: Advances and Applications
2009
Phosphine Organocatalysis
2018 Standout
Structural modification strategies for the rational design of red/NIR region BODIPYs
2014 Standout
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice
2004
An Automated Microfluidic System for Online Optimization in Chemical Synthesis
2010
Water-Soluble Phosphonate-Substituted BODIPY Derivatives with Tunable Emission Channels
2011
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Recent advances in electrophilic fluorination
1999
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Supported Ionic Liquids. New Recyclable Materials for the L‐Proline‐Catalyzed Aldol Reaction
2006
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
Synthesis of 2,2′‐Biflavanones from Flavone via Electrolytic Reductive Coupling
2002
Concise Synthesis of Anti-HIV-1 Active (+)-Inophyllum B and (+)-Calanolide A by Application of (−)-Quinine-Catalyzed Intramolecular Oxo-Michael Addition
2004
Diethyl Fluoronitromethylphosphonate: Synthesis and Application in Nucleophilic Fluoroalkyl Additions
2013
(α-Monofluoroalkyl)phosphonates: a class of isoacidic and “tunable” mimics of biological phosphates
2001
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Gold-catalyzed reactions of C–H bonds
2008
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Palladium‐Catalyzed, tert‐Butyllithium‐Mediated Dimerization of Aryl Halides and Its Application in the Atropselective Total Synthesis of Mastigophorene A
2016 StandoutNobel
Modifying the β,γ Leaving-Group Bridging Oxygen Alters Nucleotide Incorporation Efficiency, Fidelity, and the Catalytic Mechanism of DNA Polymerase β
2006 StandoutNobel
Automated batch scale-up of microwave-promoted Suzuki and Heck coupling reactions in water using ultra-low metal catalyst concentrations
2005
Total Synthesis of Robustaflavone, a Potential Anti-Hepatitis B Agent
1998
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
Antimicrobial activity of flavonoids
2005 Standout
The exciton model in molecular spectroscopy
1965 Standout
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Asymmetric Enamine Catalysis
2007 StandoutNobel
Recent advances and new concepts for the synthesis of axially stereoenriched biaryls
2015 Standout
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
2020 Standout
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel

Works of Michael T. Flavin being referenced

Biflavonoids as novel antituberculosis agents
2001
Combating multidrug-resistant Gram-negative bacterial infections
2013
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis
2004
In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model
1999
Robustaflavone, a potential non-nucleoside anti-hepatitis B agent
1998
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI
1998
In Vitro Anti-HIV Activity of Biflavonoids Isolated fromRhus succedaneaandGarcinia multiflora
1997
Amyloid fibril formation in microwell plates for screening of inhibitors
2001
Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-ones
2009
Antiviral Activities of Biflavonoids
1999
Chalcones and flavonoids as anti-Tuberculosis agents
2002
Synthesis and antiviral activities of fluorinated acyclic nucleoside phosphonates
1998
Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
2012
Synthesis of dual 14C-labeled (+)-calanolide A, a naturally occurring anti-HIV agent
1997
Structural Analogues of the Calanolide Anti-HIV Agents. Modification of the trans-10,11-Dimethyldihydropyran-12-ol Ring (Ring C)
1997
Anti-HIV-1 Activity of Calanolides Used in Combination with other Mechanistically Diverse Inhibitors of HIV-1 Replication
2000
A Versatile Approach for Synthesis of 2,3-Dimethyl Chroman-4-ones, Intermediate for Calanolide Anti-HIV Agents,VIAAldol/Mitsunobu Reactions
1996
Automated Process Research. An Example of Accelerated Optimization of the Friedel−Crafts Acylation Reaction, a Key Step for the Synthesis of Anti-HIV (+)-Calanolide A
2000
Automated Process Research and the Optimization of the Synthesis of 4(5)-(3-Pyridyl)imidazole
2000
Introduction of α-fluorophosphonomethyl ether functionality and its application to the synthesis of fluorinated acyclic phosphonate nucleosides
1996
Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products
1996
Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro
1997
AN IMPROVED SYNTHESIS OF 9-[2-(DIETHOXYPHOSPHONOMETHOXY)ETHYL]ADENINE AND ITS ANALOGUES WITH OTHER PURINE BASES UTILIZING THE MITSUNOBU REACTION
1996
Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects
2001
Synthesis, Chromatographic Resolution, and Anti-Human Immunodeficiency Virus Activity of (±)-Calanolide A and Its Enantiomers
1996
Preparation of New Wittig Reagents and Their Application to the Synthesis of α,β-Unsaturated Phosphonates
1996
Novel approach for synthesis of (±)-calanolide a and its anti-HIV activity
1995
Rankless by CCL
2026